| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6125040 | Osteoarthritis and Cartilage | 2014 | 8 Pages |
Abstract
LY2951742 is a high affinity, neutralizing antibody to CGRP. Neutralization of CGRP is efficacious in several OA pain models and works independently of NSAID mechanisms of action. LY2951742 holds promise for the treatment of pain in OA patients.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
R.J. Benschop, E.C. Collins, R.J. Darling, B.W. Allan, D. Leung, E.M. Conner, J. Nelson, B. Gaynor, J. Xu, X.-F. Wang, R.A. Lynch, B. Li, D. McCarty, J.L. Oskins, C. Lin, K.W. Johnson, M.G. Chambers,